返回
Psyence Biomedical Ltd（PBM）價格
PBM 股價走勢圖
PBM 收益
Psyence Biomedical Ltd
$0.67
-0.01%
$0
收盤價：Jan 16, 16:00:00 GMT-5
$0.68
1.62%
$0.01
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$0.6701
開盤價
$0.6882
當日範圍
$0.6167 - $0.69
52週區間
$0.662 - $17.93
交易量
506.8K
平均成交量
1.3M
每股盈餘 (TTM)
41.27
股息收益率
--
市值
$1.2M
什麼是 PBM？
Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.